{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:51:05Z","timestamp":1793757065419,"version":"4.6.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174095"],"award-info":[{"award-number":["82174095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phymed.2025.157275","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:03:51Z","timestamp":1758585831000},"page":"157275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Celastrol liposomes enhance anti-PD-L1 in triple-negative breast cancer by reprogramming immunosuppressive microenvironment driven by cancer-associated adipocytes"],"prefix":"10.1016","volume":"148","author":[{"given":"Yujie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0753-0576","authenticated-orcid":false,"given":"Guilin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.157275_bib0001","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.devcel.2020.07.014","article-title":"Small extracellular vesicle regulation of mitochondrial dynamics reprograms a hypoxic tumor microenvironment","volume":"55","author":"Bertolini","year":"2020","journal-title":"Dev. Cell."},{"key":"10.1016\/j.phymed.2025.157275_bib0002","doi-asserted-by":"crossref","first-page":"383","DOI":"10.15212\/AMM-2024-0044","article-title":"Druggability, molecular targets, and nanocarrier delivery of natural triterpenoid celastrol against chronic diseases","volume":"3","author":"Chan","year":"2024","journal-title":"Acta Materia Medica"},{"key":"10.1016\/j.phymed.2025.157275_bib0003","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2025.157275_bib0004","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41423-022-00926-6","article-title":"Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1","volume":"19","author":"Chen","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phymed.2025.157275_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113614","article-title":"Enhancing immunogenicity and release of in situ-generated tumor vesicles for autologous vaccines","volume":"381","author":"Chen","year":"2025","journal-title":"J. Controll. Rel."},{"key":"10.1016\/j.phymed.2025.157275_bib0006","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.actbio.2023.06.004","article-title":"Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer","volume":"167","author":"Ding","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.phymed.2025.157275_bib0007","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41590-020-0620-x","article-title":"PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer","volume":"21","author":"Diskin","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phymed.2025.157275_bib0008","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2025.157275_bib0009","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12964-023-01409-5","article-title":"Chemoproteomics-based profiling reveals potential antimalarial mechanism of Celastrol by disrupting spermidine and protein synthesis","volume":"22","author":"Gao","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.phymed.2025.157275_bib0010","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1039\/D1CC05986F","article-title":"Chemoproteomic profiling reveals celastrol as a potential modulator of cholesterol signaling","volume":"58","author":"Geng","year":"2022","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.phymed.2025.157275_bib0011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1470-2045(25)00028-2","article-title":"Tailoring chemoimmunotherapy de-escalation in early-stage triple-negative breast cancer","volume":"26","author":"Gon\u00e7alves","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2025.157275_bib0012","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1021\/acsnano.4c13463","article-title":"Rationally engineered bispecific nanoimmunoblocker restores anticancer immunity via dual immune checkpoint blockade","volume":"19","author":"Guan","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.phymed.2025.157275_bib0013","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2025.157275_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156514","article-title":"Celastrol-loaded ginsenoside Rg3 liposomes enhance anti-programmed death ligand 1 immunotherapy by inducing immunogenic cell death in triple-negative breast cancer","volume":"139","author":"Huang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157275_bib0015","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS21-P1-04-08","article-title":"Abstract P1-04-08: exosomes from primary breast adipocytes induce immune exhaustion in triple negative breast cancer","volume":"82","author":"Jafari","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2025.157275_bib0016","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2174\/0113816128288970240321073436","article-title":"Celastrol elicits antitumor effects through inducing immunogenic cell death and downregulating PD-L1 in ccRCC","volume":"30","author":"Li","year":"2024","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phymed.2025.157275_bib0017","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s12276-022-00856-3","article-title":"Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer","volume":"54","author":"Li","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phymed.2025.157275_bib0018","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","article-title":"Treatment of obesity with celastrol","volume":"161","author":"Liu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2025.157275_bib0019","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/HM9.0000000000000102","article-title":"Celastrol promotes apoptosis of breast cancer MDA-MB-231 cells by targeting HSDL2","volume":"4","author":"Liu","year":"2024","journal-title":"Acupunct. Herbal Med."},{"key":"10.1016\/j.phymed.2025.157275_bib0020","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1111\/cas.15916","article-title":"Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes","volume":"114","author":"Liu","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phymed.2025.157275_bib0021","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1038\/s41467-023-39920-5","article-title":"ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2025.157275_bib0022","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13046-019-1173-4","article-title":"Celastrol mediates autophagy and apoptosis via the ROS\/JNK and akt\/mTOR signaling pathways in glioma cells","volume":"38","author":"Liu","year":"2019","journal-title":"J. Experiment. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157275_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112759","article-title":"Hesperidin PLGA nanoparticles potentiate the efficacy of aPD-1 in treating triple negative breast cancer by regulating CCL2 and ADPN expression in cancer-associated adipocytes","volume":"140","author":"Luo","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2025.157275_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215616","article-title":"Contribution of adipocytes in the tumor microenvironment to breast cancer metabolism","volume":"534","author":"Lyu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.157275_bib0025","doi-asserted-by":"crossref","first-page":"eadm7269","DOI":"10.1126\/scitranslmed.adm7269","article-title":"Tumor extracellular vesicle-derived PD-L1 promotes T cell senescence through lipid metabolism reprogramming","volume":"17","author":"Ma","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phymed.2025.157275_bib0026","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/cancers11071033","article-title":"PD-1\/PD-L1 targeting in breast cancer: the first clinical evidences are emerging\u2014A literature review","volume":"11","author":"Planes-Laine","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phymed.2025.157275_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120604","article-title":"Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy","volume":"269","author":"Qiu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.phymed.2025.157275_bib0028","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-022-01557-1","article-title":"LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer","volume":"21","author":"Shen","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.157275_bib0029","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2025.157275_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13046-024-03050-7","article-title":"Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM\/PD-L1 signaling","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2025.157275_bib0031","article-title":"MFGE8 induces anti-PD-1 therapy resistance by promoting extracellular vesicle sorting of PD-L1","volume":"6","author":"Wang","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.phymed.2025.157275_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217486","article-title":"Tumor-derived extracellular vesicle PD-1 promotes tumor immune evasion via disruption of peripheral T cell homeostasis","volume":"612","author":"Wang","year":"2025","journal-title":"Cancer Lett"},{"key":"10.1016\/j.phymed.2025.157275_bib0033","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Challenges coexist with opportunities: spatial heterogeneity expression of PD-L1 in cancer therapy","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.phymed.2025.157275_bib0034","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-022-01297-1","article-title":"Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis","volume":"15","author":"Xie","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phymed.2025.157275_bib0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","article-title":"Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phymed.2025.157275_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207686","article-title":"Gold nanobipyramid-mediated apoptotic camouflage of adipocytes for obesity immunotherapy","volume":"35","author":"Yan","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phymed.2025.157275_bib0037","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41422-018-0060-4","article-title":"Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth","volume":"28","author":"Yang","year":"2018","journal-title":"Cell. Res."},{"key":"10.1016\/j.phymed.2025.157275_bib0038","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41571-022-00717-y","article-title":"Thermal immuno-nanomedicine in cancer","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2025.157275_bib0039","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.immuni.2025.03.002","article-title":"Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer","volume":"58","author":"Yu","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2025.157275_bib0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1470-2045(24)00757-5","article-title":"Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902\/IBCSG 61\u201320; Neo-N): a non-comparative, open-label, randomised, phase 2 trial","volume":"26","author":"Zdenkowski","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2025.157275_bib0041","article-title":"Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma","author":"Zhang","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.phymed.2025.157275_bib0042","article-title":"Chronic stress-induced and tumor derived SP1+ exosomes polarizing IL-1\u03b2+ neutrophils to increase lung metastasis of breast cancer","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.phymed.2025.157275_bib0043","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Zhang","year":"2021","journal-title":"Cancer Cell"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325009146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325009146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:05:20Z","timestamp":1769810720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325009146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"alternative-id":["S0944711325009146"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157275","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol liposomes enhance anti-PD-L1 in triple-negative breast cancer by reprogramming immunosuppressive microenvironment driven by cancer-associated adipocytes","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157275"}}